Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-07-12
1993-04-06
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3147
Patent
active
052004180
ABSTRACT:
This invention relates to the amelioration of cryptosporidiosis symptoms, such as diarrhea, caused by the parasite crypotosporidium in susceptible host animals using effective amounts of decoquinate.
REFERENCES:
patent: 3485845 (1969-12-01), Davis et al.
Bovine Veterinary Forum, Focus: Cryptosporidiosis, Apr. 1990, vol. 5, No. 1, pp. 1-16.
Deccox.RTM. Product Summary, trade literature of Rhone-Poulenc, technical Manual pp. 1-8.
Kirkpatrick et al., "Cryptosporidiosis" Continuing Education Article #9, The Compendum on Continuing Education, vol. 6, No. 3, Mar. 1984, pp. S154-S164.
J. A. Moore et al., "Cryptosporidiosis in Animals Including Humans", Continuing Education Article #1, Compendum Small Animal, vol. 10, No. 3, Mar. 1988, pp. 275-283.
K. W. Angus et al., "Prophylatic effects of anticoccidial drugs in experimental murine cryptosporidiosis", The Veterinary Record, Feb. 18, 1984, pp. 166-168.
"Management of Cryptosporidiosis", J. Antimicrobial Chemotherapy, V. 15, 1985, pp. 3-4.
Fox James E.
Redman Donald R.
Foster Frank H.
Rhone-Poulenc Inc.
Schenkman Leonard
The Ohio State University
LandOfFree
Cryptosporidiosis amelioration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cryptosporidiosis amelioration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cryptosporidiosis amelioration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-536975